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Summary
An overproduction of reactive oxygen species
(ROS) mediated by NADPH oxidase 2 (NOX2) has
been related to airway inflammation typical of influ-
enza infection. Virus-induced oxidative stress may
also control viral replication, but the mechanisms
underlying ROS production, as well as their role in
activating intracellular pathways and specific
steps of viral life cycle under redox control have to
be fully elucidated. In this study, we demonstrate
that influenza A virus infection of lung epithelial
cells causes a significant ROS increase that
depends mainly on NOX4, which is upregulated
at both mRNA and protein levels, while the ex-
pression of NOX2, the primary source of ROS in
inflammatory cells, is downregulated. Inhibition
of NOX4 activity through chemical inhibitors or
RNA silencing blocks the ROS increase, pre-
vents MAPK phosphorylation, and inhibits viral
ribonucleoprotein (vRNP) nuclear export and
viral release. Overall these data, obtained in cell
lines and primary culture, describe a so far un-
recognized role for NOX4-derived ROS in activat-
ing redox-regulated intracellular pathways during
influenza virus infection and highlight their
relevance in controlling specific steps of viral rep-
lication in epithelial cells. Pharmacological modu-
lation of NOX4-mediated ROS production may
open the way for new therapeutic approaches to
fighting influenza by targeting cell and not the
virus.
Introduction
An alteration of the intracellular redox balance, which
occurs during several viral infections, is associated with
the progression of virus-induced diseases (Beck et al.,
2000; reviewed in Nencioni et al., 2011). This redox
imbalance can be determined by several factors, includ-
ing an overproduction of reactive oxygen species (ROS)
(Petherans et al., 1987; Elbim et al., 2001; Machida
et al., 2006; Imai et al., 2008; Hu et al., 2011) and/or a
decrease of reduced glutathione (GSH), the main intra-
cellular non-enzymatic antioxidant (Cai et al., 2003;
Nencioni et al., 2003). We previously reported that,
during viral infections, the decrease of intracellular GSH
varies in intensity, duration and mechanism of induction
depending on the type of virus and the infected host cell
(Garaci et al., 1992; 1997; Palamara et al., 1995; 1996;
Ciriolo et al., 1997). Regarding influenza virus infection,
we found that such GSH decrease was pivotal for viral
replication (Nencioni et al., 2003) by allowing the folding
and maturation of viral haemagglutinin (HA) (Sgarbanti
et al., 2011). We also demonstrated that administration
of GSH-C4 (a hydrophobic glutathione derivative that
increases intracellular GSH) strongly impaired the repli-
cation of several influenza virus strains (Sgarbanti et al.,
2011), confirming the important role of low GSH levels in
the life cycle of this virus.
Since GSH exerts an efficient buffering role against
ROS (Bindoli et al., 2008; Mieyal et al., 2008), a defi-
ciency of GSH puts the cell at risk for oxidative damage
from ROS and related reactive species. The main source
of deliberate cellular ROS production is the family of
NADPH (nicotinamide adenine dinucleotide phosphate)
oxidases (NOXs), which consists of seven members –
NOX1- to -5 and the two dual oxidases, Duox1 and Duox2
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– expressed in most cell types (Bedard and Krause,
2007). These enzymes, which generate superoxide anion
or hydrogen peroxide as primary products (Katsuyama
et al., 2011), function in physiological and pathological
processes as well as in the defence against infection. In
phagocytic cells, NOX2 is the main isoform responsible
for the respiratory burst that results in the release of
superoxide in the phagocytic vacuole and promotes bac-
terial killing. At the same time, NOX2 production of ROS
aggravates airway inflammation during influenza A virus
infection: as shown in mice lacking NOX2, in the absence
of ROS production, the severity of symptoms was miti-
gated (Snelgrove et al., 2006; Vlahos et al., 2011). NOXs
are also involved in viral infections in non-phagocytic
cells. For example, in airway epithelial cells, NOX2 was
the specific source of ROS responsible for NF-κB activa-
tion and cytokine production during respiratory syncytial
virus and Sendai virus infections (Fink et al., 2008). In
hepatocytes, hepatitis C virus stimulated NOX4 expres-
sion and ROS generation, implicating this enzyme in
inflammatory liver disease (Boudreau et al., 2009). In
non-infected endothelial cells, NOX4 has been shown to
stimulate intracellular signalling cascades such as that of
mitogen-activated protein kinase (MAPK) pathways
including p38 (Jaulmes et al., 2009) and ERK (Wu et al.,
2010).
These cascades may also play a role in influenza
virus replication. In particular, activation of p38 and
ERK MAPK is required for the nuclear export of viral
ribonucleoprotein (vRNP) complexes (Pleschka et al.,
2001; Marjuki et al., 2006; Nencioni et al., 2009). The
mechanisms through which influenza and other viruses
activates MAPK have been deeply investigated. Marjuki
et al. (2006) showed that activation of the ERK cascade
is related to membrane accumulation of viral HA. In Rhi-
novirus infection, the activation of p38 MAPK depends
on the accumulation of double-strand RNA (Gern et al.,
2003). To date, however, the potential role of virus-
induced ROS production on MAPK activation, the steps
of viral life cycle under redox control, as well as the
mechanisms through which influenza virus induces ROS
production remain to be fully elucidated. Therefore, in
the present study, we investigated, in lung epithelial cell
lines and primary airway epithelial cells, the mechanisms
underlying influenza virus-induced redox imbalance and
its role in virus life cycle. Here we demonstrate that: (1)
influenza virus induces oxidative stress through a mod-
erate but significant increase of the production of ROS
and a depletion of GSH; (2) influenza virus infection
transiently upregulates NOX4 mRNA and protein expres-
sion; (3) NOX4-derived ROS activate p38 and ERK1-2
MAPK that, in turn, are involved in nuclear export
of vRNP; and (4) NOX4 activity is required for viral
replication.
Results
Influenza virus alters GSH redox homeostasis and
increases ROS in lung epithelial cells
Since GSH plays a fundamental role in buffering ROS,
we investigated whether the GSH decrease induced
by influenza virus was associated with changes in intra-
cellular ROS levels. Confluent monolayers of human
mucoepidermoid pulmonary carcinoma cells (NCI-H292)
were infected with 1 MOI (multiplicity of infection) of influ-
enza virus (A/Puerto Rico/8/34 H1N1) (PR8) to allow
single-cycle replication. After viral adsorption, at different
time points, the content of intracellular GSH was evalu-
ated by high-performance liquid chromatography (HPLC),
while ROS production was measured in a cytofluorimetric
assay using the ROS-sensitive probe dichlorodihydro-
fluorescein diacetate (DCF-DA). As expected (Sgarbanti
et al., 2011), viral infection was associated with a
decrease in GSH levels over time (Fig. 1A). GSH content
in infected cells was significantly different from that of
mock-infected control cells at 6 h after infection (37%
lower, P < 0.01, Student’s t-test). ROS production under-
went a transient but significant increase in infected cells,
starting at 3 h and disappearing by 6 h (P < 0.05)
(Fig. 1B). Since the GSH drop caused by infection was
temporally downstream of the ROS increase, we hypoth-
esized that the GSH decrement was, at least in part,
due to ROS scavenging activity. To test this possibility,
mock-infected and infected cells were treated with the
antioxidant Trolox, a cell-permeable water-soluble ana-
logue of vitamin E, and ROS and GSH levels were quan-
tified when the greatest differences between infected and
control cells were observed (Fig. 1B and A respectively).
Treatment with Trolox prevented the ROS increase
(Fig. 1C) and blocked the GSH decrease due to infection
(Fig. 1D), implying that depletion of GSH resulted from its
consumption while buffering against ROS. The fact that
Trolox addition also reduced ROS accumulation in control
cells confirmed its ability to scavenge free radicals
(Fig. 1C).
NADPH oxidases are involved in influenza virus-induced
ROS production
Given the increasing evidence that NOXs are implicated
in the severity of influenza and other viral infections, we
investigated whether these enzymes were responsible for
the ROS overproduction during influenza infection of epi-
thelial cells. To this aim, NCI-H292 cells were infected as
described above and treated with diphenyleneiodonium
(DPI), a broad-spectrum inhibitor of flavoenzymes includ-
ing NOXs (Wind et al., 2010), just after viral challenge.
DPI treatment reduced ROS levels in control cells and,
importantly, inhibited any increase in ROS content in
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infected cells (Fig. 2A). In parallel, DPI treatment raised
GSH levels in control cells (possibly because, in cells
producing less ROS, there was lower consumption of
GSH) and prevented the intracellular GSH depletion
observed during infection (Fig. 2B). These results support
the hypothesis that the GSH depletion during infection
is due to its ROS buffering function and suggest that
NOXs are involved in the observed virus-induced redox
imbalance.
NCI-H292 cells express all seven NOX isoforms (Kim
et al., 2011 and data not shown). To determine which
isoform is involved in virus-induced ROS overproduction,
we measured the expression of these enzymes during
viral replication. To this aim, the cells were infected with
PR8, cultured for up to 6 h, and assayed for NOX mRNA
using RT-qPCR. In these experimental conditions, influ-
enza virus only modulated the transcription of NOX2 and
NOX4 mRNA (Fig. 3A), whereas the other NOX mRNAs
were not significantly affected by infection (data not
shown). Interestingly, the virus had differential effects on
these two isoforms, reducing NOX2 mRNA while increas-
ing NOX4 mRNA transiently with a peak at 3 h. Similar
results were obtained at the protein level: NOX2 protein
decreased (Fig. 3B) while that of NOX4 increased
(Fig. 3C). The trend of NOX4 protein increase mirrored
that of the ROS elevation (Fig. 1B), suggesting that NOX4
is the isoform that plays the leading role in virus-induced
redox imbalance.
NOX4-derived ROS activate p38 and ERK1-2 MAPK to
regulate the influenza virus life cycle
Given that NOX4-derived ROS are known to activate p38
and ERK1-2 MAPK in non-phagocytic cells, we investi-
gated whether this was true even in the context of influ-
enza virus infection by analysing the phosphorylation
Fig. 1. Influenza A virus infection depletes GSH and increases ROS production.
A. Intracellular GSH content in mock-infected (Ctr) and PR8 virus-infected (I) NCI-H292 cells over time; data are from three experiments each
done in duplicate (n = 6).
B. Time-course of intracellular ROS levels in PR8 virus-infected NCI-H292 cells; data are from three separate experiments each done in
triplicate (n = 9). DCF+ cells, cells positive for the ROS-sensitive probe DCF-DA.
C. ROS levels in mock-infected and infected NCI-H292 cells, cultured in the absence or presence of 200 μM Trolox (Tx) for 3 h after the viral
challenge. Treatment with tert-butyl hydroperoxide (tb) was used as positive control. Data are from three separate experiments each done in
triplicate (n = 9).
D. GSH content in mock-infected and infected NCI-H292 cells, cultured without or with 200 μM Trolox for 6 h after the viral challenge; data are
from three separate experiments each done in duplicate (n = 6). All values are expressed as mean and SD. *P versus control, §P versus
infected, Student’s t-test.
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state of these kinases. As expected, influenza virus infec-
tion activated the kinases, seen as an increase in the
phosphorylated forms (Fig. 4A and B). Treatment with DPI
strongly inhibited the phosphorylation of p38 MAPK
(Fig. 4A, upper panel) and of ERK1 (Fig. 4A, bottom
panel). Since NOX4 is the only NOX isoform whose
expression is upregulated in our experimental model,
these data suggest that also during influenza virus infec-
tion NOX4-derived ROS activate MAPK. Because these
kinase cascades are needed for vRNP trafficking, we
evaluated the effect of DPI on the intracellular localization
of influenza A nucleoprotein (NP) over time (Fig. 4C).
Without DPI (top row of images), viral nucleoprotein pro-
gressively migrated from the nucleus to the cytoplasm;
instead, the presence of DPI (bottom row) impaired NP
export, leaving it confined within nuclei even at 6 h. Alto-
gether, these data suggest that NOX4-related ROS pro-
duction is pivotal for p38 and ERK MAPK activation,
which, in turn, stimulate nuclear export of NP.
We next examined if NOX4 is needed for viral replica-
tion. First, we assayed the release of viral particles from
cells infected with PR8 virus strain over 8 h, in the
absence or presence of DPI at different concentrations
(5, 10, 20 μM) through the haemagglutination assay. We
found that viral titre was reduced in a dose-dependent
manner in DPI-treated cells by about 90% at 10 and
20 μM (P < 0.01, Student’s t-test) (Fig. 5A). Because the
degree of inhibition at 10 and 20 μM was super-
imposable, we decided to utilize the concentration 10 μM
in the next experiments. These findings were confirmed
also in plaque assay, where the number of plaque
forming units (PFU) per millilitre of culture medium from
DPI-treated cells was reduced by about 1.5 log
(P < 0.001, Student’s t-test) (Fig. 5B), and in an assay of
the 50% tissue culture infectious dose (TCID50) which
showed a 90% reduction due to DPI (data not shown).
Interestingly, the ability of DPI in inhibiting viral titre was
also observed in NCI-H292 cells infected with A/parrot/
Ulster/73 and A/NWS/33 influenza viruses (Fig. S1A).
Furthermore, A549 human lung carcinoma cells were
infected with human and avian viruses (10 MOI) and
treated or not with DPI for 8 h; the haemagglutination
assay demonstrated that DPI inhibited replication of the
viruses, by about 60% (Fig. S1B). Since DPI is a general
inhibitor of flavoenzymes, we also used VAS2870, a
broad-spectrum NOX inhibitor (Wingler et al., 2012)
that does not possess intrinsic antioxidant activity and
does not inhibit other flavoproteins (Altenhofer et al.,
2012). The haemagglutination assay showed a dose-
dependent reduction in viral titre, reaching 85% at 30 μM
(P < 0.0001, Student’s t-test) (Fig. 5C). Similar results
were obtained with the plaque assay (1.3 log inhibition
versus untreated cells, P < 0.01; Fig. 5D). To further
investigate the role of NOX4 in controlling viral replica-
tion, we verified the effect of DPI and VAS2870 on the
replication of H3N2 and pandemic H1N1 2009, two cur-
rently circulating influenza A viruses. The TCID50 assay
showed that both the inhibitors strongly reduced the rep-
lication of the viruses up to 48 h after the viral challenge
(P < 0.001; P < 0.01) (Fig. 5E and F). These results dem-
onstrated that the effect of DPI and VAS2870 was not
only due to a delay on virus replication and that was
independent of the strain used. To confirm the role of
NOX4 in regulating the influenza virus life cycle, we used
short hairpin RNA (shRNA) to specifically knockdown
NOX4 gene expression. NCI-H292 cells were transfected
with a pool of NOX4 shRNA expression plasmids and
24 h later were collected for analysis: Western blotting
Fig. 2. NADPH oxidases are involved in influenza virus-induced oxidative stress.
A. Intracellular ROS levels in mock-infected (Ctr) and infected (I) NCI-H292 cells, cultured in the absence or presence of 10 μM DPI for 3 h
after the viral challenge; data are from three separate experiments each performed in triplicate (n = 9). DCF+ cells, cells positive for the
ROS-sensitive probe dichlorodihydrofluorescein diacetate.
B. Intracellular GSH content in mock-infected (Ctr) and infected (I) NCI-H292 cells, cultured without or with DPI for 6 h after the viral
challenge; data are from three separate experiments each performed in duplicate (n = 6). All values are expressed as mean and SD. *P
versus control, §P versus infected, Student’s t-test.
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revealed that the level of NOX4 protein was reduced by
about 60% compared to that measured in cells
transfected with non-targeting shRNA (Fig. 6A). In this
condition, transfected cells were infected with PR8 for
24 h. A significant reduction in viral particle release was
observed in both haemagglutination (Fig. 6B) and plaque
assays (Fig. 6C). Importantly, ROS production in cells
silenced for NOX4 and infected with influenza virus was
significantly lower compared to infected cells transfected
with non-targeting shRNA (Fig. 6D). Similar results were
obtained when the experiment was repeated in human
embryonic kidney (HEK-293) cells (Fig. S2). Altogether,
these data indicate that NOX4 plays an essential role in
virus-induced ROS production and in supporting influ-
enza virus replication in different cell lines.
NOX4 supports influenza virus replication in primary
lung epithelial cells
To determine if the results obtained in cell lines could also
be observed in primary cultures, we repeated the experi-
ments in primary airway epithelial cells from BALB/c mice
using mouse-adapted PR8 virus. Viral infection increased
the level of NOX4 protein while it decreased NOX2
(Fig. 7A), as already observed in NCI-H292 cells. Viral
infection also increased the phosphorylation state of p38
Fig. 3. NOX4 expression is increased during influenza virus infection.
A. Real-time qPCR assay of NOX isoform levels in PR8 virus-infected NCI-H292 cells, normalized to levels in mock-infected cells. NOX2 and
NOX4 levels changed over time. Values are mean and SD of three independent experiments (**P < 0.01; ***P < 0.001, Student’s t-test).
B. Western blot of uninfected (Ctr) and PR8 virus-infected NCI-H292 cells up to 6 h, using antibodies against NOX2 (left panels) and NOX4
(right panels). Actin was used as loading control for densitometric analysis of three independent experiments (bottom).
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Fig. 4. NOX-produced ROS activate p38 MAPK and ERK1-2, permitting nuclear export of viral ribonucleoprotein.
A. Mock-infected (Ctr) and PR8 virus-infected (I) NCI-H292 cells, treated or not with DPI, were collected at 6 h and subjected to Western
blotting with antibodies against p38 MAPK and its phosphorylated form (P-p38) (top), and ERK1-2 and their phosphorylated forms (bottom).
B. Densitometric analysis of p38 (top) and ERK1 (bottom) protein levels. Values are ratios of the phosphorylated isoform to the total,
normalized to the ratio obtained in control cells. Data are representative of two independent experiments (*P < 0.05; **P < 0.001, Student’s
t-test).
C. Immunofluorescence photomicrographs of NCI-H292 cells infected with PR8 virus (I) and then cultured in the absence (top) or presence
(bottom) of DPI for up to 6 h. Cells were labelled with monoclonal anti-influenza A nucleoprotein (NP) antibody followed by an Alexa Fluor
568-conjugated secondary antibody (red); nuclei were stained with DAPI (blue). Images are representative of two experiments.
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and of ERK1-2 MAPK, but the addition of DPI inhibited the
activation of the two kinases (Fig. 7B). In the presence of
DPI, the localization of NP was mainly nuclear (Fig. 7C).
Western blotting analysis demonstrated that DPI treat-
ment strongly inhibited the expression of HA, NP and
matrix 1 protein to about 20–40% of that of infected,
untreated cells (Fig. 7D). Finally, the viral titre of the
culture medium of infected cells treated with DPI was
significantly lower than that from untreated cells (Fig. 7E).
Altogether, these results demonstrate that NOX4 activity
is also important for influenza virus propagation in primary
airway epithelial cells.
Fig. 5. NOX4 supports influenza virus replication in NCI-H292 cells.
A. Cells were infected with PR8 virus and cultured in the absence or presence of DPI for 8 h before the conditioned medium was assayed.
Haemagglutination assay (**P < 0.01).
B. Plaque assay for PR8-infected cells treated or not with DPI 10 μM. PFU, plaque-forming units (**P < 0.001).
C and D. PR8-infected cells were cultured in the absence or presence of VAS2870 for 8 h. (C) Haemagglutination assay (***P < 0.0001).
(D) Plaque assay (*P < 0.01).
E. MDCK cells were infected with H3N2 virus and cultured in the absence or presence of DPI or VAS2870 for 24 and 48 h. TCID50 assay
(**P < 0.001; *P < 0.01).
F. MDCK cells were infected with pandemic 2009 H1N1 virus and cultured in the absence or presence of DPI or VAS2870 for 24 and 48 h.
TCID50 assay (*P < 0.01).
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Discussion
This study has shown that influenza A virus infection of
lung epithelial cells transiently increases intracellular ROS
as an essential step in the progression of the virus life
cycle. This process results in the activation of the p38
and ERK1-2 MAPK pathways that, in turn, promote the
nuclear export of vRNP, a key event for viral assembly and
release. In human pulmonary carcinoma cell lines and
in murine primary airway epithelial cells, the NADPH
oxidase NOX4 was the prime actor in the virus-induced
oxidative stress and, as a consequence, in the promotion
of viral replication: NOX4 expression transiently increased
during infection, while inhibition or knockdown of NOX4
reduced infected cells’ ability to produce viral particles.
The ROS increase observed upon influenza A virus
infection in our experimental system was attributed to an
upregulation of NOX4 at the mRNA and protein levels,
accompanied by the downregulation of NOX2 (and no
change in other NOXs). The activity of both NOX4 and
NOX2 is regulated, at least in part, at the transcriptional
level. Therefore, it is possible to speculate that influenza
virus exerts a positive and a negative regulatory effect on
NOX4 and NOX2 promoters, respectively, through the
binding of some viral proteins to DNA, or through the
activation of specific intracellular signalling pathways and
their downstream transcription factors (Boudreau et al.,
2009; Katsuyama et al., 2011). A number of DNA-binding
proteins were shown to interact with the NOX2 promoter
region, among which the transcriptional repressors CDP
and HoxA10 (Skalnik et al., 1991; Lindsey et al., 2005).
Therefore, influenza virus could increase DNA-binding
activity of these repressors. As concern NOX4 several
factors have been identified that regulate NOX4 transcrip-
tion among which NF-κB, the JAK/STAT pathway, the
TGF-β1, IRE-1 (Katsuyama et al., 2011). Given that
NOX4 is mainly localized in nuclei and endoplasmic
reticulum (ER), two cellular compartments under redox
control and exploited by influenza virus for two important
steps of its own replication, we hypothesized that influ-
enza virus increases the transcriptional level of NOX4 to
favouring its replication cycle.
Fig. 6. A. NCI-H292 cells were transfected with plasmids encoding shRNAs specific to NOX4 or with a control plasmid encoding a
non-targeting shRNA. The Western blot was sequentially probed with anti-NOX4 antibody and anti-tubulin antibody. Densitometry values are
ratios of intensities of the NOX4 band to the tubulin band, normalized to the ratio obtained from non-targeting cells. The blot is shown from
one representative experiment out of the two performed.
B and C. Viral load in medium of NCI-H292 cells transfected with NOX4-targeting or non-targeting shRNA expression plasmids before
infection with PR8. (B) Haemagglutination assay (**P < 0.001). (C) Plaque assay (**P < 0.01).
D. Intracellular ROS levels in NCI-H292 cells transfected with NOX4-targeting or non-targeting shRNA expression plasmids before infection
with PR8. Data are from three separate experiments (n = 3). Data are expressed as ratio of the infected cells to the non-infected ones
(**P < 0.01).
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Fig. 7. NOX4 is required for influenza virus replication in primary airway epithelial cells from BALB/c mice.
A. Western blot of uninfected (Ctr) and PR8-infected (I) cells, using antibodies against NOX4 (upper panel) and NOX2 (bottom panels).
Tubulin was used as loading control. Data are representative of three independent experiments.
B. Mock-infected (Ctr) and PR8-infected (I) cells, treated or not with DPI, were collected at 8 h and subjected to Western blotting with
antibodies against p38 MAPK and its phosphorylated form (P-p38) (top), and ERK1-2 and their phosphorylated forms (bottom). Data are
representative of two independent experiments.
C. Immunofluorescence photomicrographs of cells infected with PR8 and then cultured in the absence (left) or presence (right) of DPI for up to
8 h. Cells were labelled with monoclonal anti-influenza A nucleoprotein antibody followed by an Alexa Fluor 568-conjugated secondary
antibody (red).
D. Mock-infected (Ctr) and PR8-infected (I) cells, treated or not with DPI, were collected at 8 h and subjected to Western blotting with goat
polyclonal anti-influenza A virus antibody. Actin was used as loading control.
E. Viral load in medium above PR8-infected cells, cultured in the absence or presence of DPI for 24 h. Haemagglutination assay
(***P < 0.001).
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On the other hand, since NOX2 regulates the antiviral
response of host cells in other viral infections
(Soucy-Faulkner et al., 2010), it is possible that in lung
epithelial cells influenza virus downregulates the NOX2
isoform to evade the host innate responses, in order to
complete its life cycle. Indeed, it is known that influenza
virus uses another mechanism to contrast the innate
immune response, namely the blocking of type I IFN-
mediated antiviral responses by the viral non-structural
(NS1) protein (Garcia-Sastre et al., 1998; Geiss et al.,
2002; Imai et al., 2010).
Recent research has shown that the ROS overproduc-
tion that follows infection by HCV in liver (Boudreau et al.,
2009) and encephalomyocarditis virus in brain (Ano et al.,
2010) is due to the activation of NOX4 and NOX2 respec-
tively. The latter enzyme is involved in NF-κB activation
during infection with respiratory syncytial and Sendai
viruses, leading to an excessive inflammatory response
(Fink et al., 2008). Moreover, NOX2 activity is responsible
for airway inflammation following infection with low and
high pathogenicity influenza A virus strains (Snelgrove
et al., 2006; Vlahos et al., 2011).
An excessive ROS production due to an overactive
innate immune response was responsible for much of the
acute lung injury caused by highly pathogenic (H5N1)
influenza virus (Imai et al., 2008). Accordingly ROS gen-
eration may act as a stress signal for the formation of the
inflammasome complex, which is crucial for the produc-
tion of pro-inflammatory cytokines (Rubartelli et al., 2011;
Kaushik et al., 2012). A mild ROS flux which is in line with
the low ROS increase observed in our results, is able to
induce signalling cascades including the MAPK cascade
(Filomeni et al., 2003; Torres and Forman, 2003; Vigilanza
et al., 2008). These pathways are also important in stimu-
lating the overproduction of cytokines and chemokines
during acute influenza (Lee et al., 2005; Borgeling et al.,
2013). Interestingly, activation of MAPK cascades is also
necessary for progression of the virus life cycle, as shown
here and earlier (Pleschka et al., 2001; Marjuki et al.,
2006; Nencioni et al., 2009; Marchant et al., 2010).
Our results highlight a novel signalling pathway induced
by influenza virus infection that brings about MAPK acti-
vation involving NOX4 as a central regulator. Interestingly,
p38 and ERK1-2 MAPK are involved in the regulation of
influenza virus replication by controlling nucleocyto-
plasmic traffic of vRNP through different mechanisms
(Pleschka et al., 2001; Marjuki et al., 2006; Nencioni
et al., 2009). In particular, we previously demonstrated
the involvement of p38 MAPK in nucleoprotein phos-
phorylation, a key event for the export of vRNP complexes
from the nucleus to the cytoplasm (Nencioni et al., 2009).
Indeed, inhibition of p38 MAPK impaired nucleoprotein
phosphorylation, vRNP nucleocytoplasmic translocation
and, consequently, viral replication. As concerns the
ERK1-2 pathway, Pleschka et al. (2001) showed that ERK
inhibition caused the nuclear retention of vRNP com-
plexes, by impairing the function of the viral nuclear export
protein (NEP/NS2), and reduced viral production. In
line with these findings, DPI treatment in this study
blocked the nuclear export of NP, confirming the role of
p38 MAPK and ERK1-2 in vRNP trafficking. Importantly,
the same results were also observed in primary lung
cells from mice, suggesting that our results may also be
valid in vivo.
The use of DPI in our experimental model impaired viral
replication more than that achieved with specific MAPK
inhibitors as reported by others (Pleschka et al., 2001;
Nencioni et al., 2009), probably due to inhibition of redox-
sensitive cellular factors controlling various steps of virus
life cycle, including nucleocytoplasmic NP export and viral
protein synthesis. Also, we cannot rule out that DPI could
inhibit other intracellular signalling molecules involved in
vRNP traffic, such as protein kinase C (Bui et al., 2000;
Palamara et al., 2005) and redox-sensitive folding factors
responsible for viral glycoprotein maturation (Sgarbanti
et al., 2011). The latter is largely mediated by the redox-
sensitive host-cell protein disulfide isomerase (PDI),
whose redox state determines its ability to form disulfide
bonds (oxidation) or reduce them. Oxidation of this
isomerase is one of the rate-limiting steps in oxidative
protein folding (Chakravarthi and Bulleid, 2004).
Sgarbanti et al. (2011) demonstrated that treatment of
influenza virus infected cells with a GSH derivative (GSH-
C4) increased the reduced form of the isomerase and
inhibited the disulfide bond formation needed for HA matu-
ration, by restoring intracellular GSH content. Here we
showed a strong reduction of HA expression after DPI
treatment. Thus, since NOX4 localizes in endoplasmic
reticulum of various cell types (Martyn et al., 2006) we can
speculate that in our model, NOX4-derived ROS can
favour the oxidation of PDI and, consequently, the matu-
ration process of HA. Further studies are in progress to
deepen this concern.
Overall, this study shows that redox-sensitive intracel-
lular pathways play an important role in viral replication
and suggests that modulation of NOX4 activity could rep-
resent a new pharmacological approach for controlling
the replication of different influenza viruses. The global
spread of the 2009 pandemic H1N1 influenza virus and
the emergence of viral strains resistant to antiviral agents
underlined the limits of currently used strategies for con-
trolling influenza (reviewed in De Clercq, 2012). To date,
vaccination represents the best anti-influenza strategy
(both for prophylaxis and control), but vaccines cannot be
produced quickly enough to be ready at the start of a
pandemic. Therefore, the discovery of molecules affecting
host-cell factors essential for viral replication may help
design therapies with greater effectiveness towards differ-
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ent virus types and lower probability that the infectious
agents develop resistance. Interestingly, it has recently
been demonstrated that modulation of redox state with
GSH or its derivatives altered the Th1/Th2 balance in
favour of a Th1-type immune response, which is important
for the antiviral response (Fraternale et al., 2011). There-
fore, restoration of the redox state in infected cells may be
an effective way to control viral infection, by inhibiting viral
replication, moderating the inflammatory response, and
improving the host cells’ immune responses.
Experimental procedures
Cell lines and primary cultures
NCI-H292 human mucoepidermoid pulmonary carcinoma cells
and MDCK Madine Darby canine kidney cells were grown
in RPMI 1640 medium supplemented with 10% fetal bovine
serum (FBS), 0.3 mg ml−1 glutamine, 100 U ml−1 penicillin and
100 μg ml−1 streptomycin. A549 human carcinoma cells and
HEK-293 human embryonic kidney cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% FBS, 0.3 mg ml−1 glutamine, 100 U ml−1 penicillin and
100 μg ml−1 streptomycin.
Harlan BALB/c mice (6- to 8-week-old females) were housed
and studied under Institutional Animal Care and Use Committee–
approved protocols. Primary alveolar epithelial cells (AEC) were
isolated as described previously (Corti et al., 1996) with some
modifications. Briefly, mice were anesthetized by an overdose of
isofluorane, heparinized and exsanguinated by cutting the infe-
rior vena cava. Lungs were perfused with sterile phosphate-
buffered saline (PBS) via the right ventricle until the effluent was
visually free of blood. A small incision was made into the exposed
trachea to insert a shortened cannula and 1.5 ml sterile dispase
solution (BD Biosciences) was administered into the lung. After 2
minutes, the lungs were excised and placed in culture tubes each
containing 2 ml dispase solution and gently agitated at room
temperature for 45 minutes. Lungs were then minced and sus-
pended in 2 ml dispase solution containing 2 μg ml−1 collagenase
and 0.01% DNase. Digested lungs were resuspended in DMEM
containing 10% FBS, and sequentially filtered through 70-, 40-,
20-μm nylon mesh filters (BD Falcon). The resulting cell suspen-
sion was centrifuged. After resuspension in DMEM, cells under-
went negative selection by using biotinylated anti-CD16/32,
anti-CD45 and anti-CD31 antibodies (Miltenyi Biotec) followed
by binding to streptavidin-coated magnetic particles (Miltenyi
Biotec), according to the manufacturer’s instructions. The non-
bound cell fraction consisting of AECs had > 90% purity, as
assessed by immunofluorescence staining for cytokeratin. The
cells were seeded in 24-well culture plates at a density of 3 × 105
cells per well in DMEM supplemented with 10% FBS and antibi-
otics, and subjected to virus infection on day 3 when they were
about 90% confluent.
Influenza virus production, cell infection and viral
titre assays
Influenza virus A/Puerto Rico/8/34 H1N1 (PR8), Influenza
A/parrot/Ulster/73 (H7N1) (Ulster 73), a subtype of low patho-
genicity obtained from the Istituto Zooprofilattico delle Tre
Venezie, Padua, Italy, and A/NWS/33 (H1N1) (NWS 33) (ATCC
VR-219), a neurotropic strain of human influenza virus derived
from the WS strain by intracerebral inoculation of mice, were
grown in the allantoic cavities of 10-day-old embryonated chicken
eggs. Influenza pandemic 2009/H1N1 isolated from clinical
samples at ‘Sapienza’ University of Rome was kindly provided by
Prof. Antonelli, while Influenza A H3N2/Florence/07 isolated from
clinical samples at University of Florence was kindly provided by
Prof. Azzi and Dr. Giannecchini.
NCI-H292 and A549 cells were plated, grown for 24 h, and
then challenged with influenza virus diluted in serum-free
medium at different multiplicity of infection (MOI). Mock infection
was performed with the same dilution of allantoic fluid from
uninfected eggs. Cells were incubated in presence of the virus for
1 h at 37°C. After the viral challenge, mock-infected and virus-
infected cells were washed with PBS and then cultured with fresh
medium containing 2% FBS and experimental reagents until use.
Primary AECs were challenged with mouse-adapted PR8 diluted
in serum-free medium at 0.05 MOI for 2 h, after which the inocu-
lum was removed and the cells were washed with PBS and then
cultured with fresh medium containing 2% FBS and experimental
reagents.
Viral titre of conditioned culture medium was assayed using the
haemagglutination assay (Mahy, 1991), the plaque assay and the
50% tissue culture infective dose (TCID50) assay. The plaque
assay was done using confluent monolayers of MDCK cells in
24-well plates according to the standard procedure (Gaush and
Smith, 1968). For the TCID50 assay, confluent monolayers of
MDCK cells in 96-well plates were inoculated with 10-fold dilu-
tions of the samples (8 wells per dilution), and incubated for 3
days; wells showing positive cytopathic effects were counted,
and the TCID50 titre was interpolated using the Reed-Muench
method (Reed and Muench, 1938).
Cell treatments
For treatment with the antioxidant 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox; Sigma), the com-
pound was dissolved in ethanol and then applied to cells at a final
concentration of 200 μM in RPMI containing 2% FBS. Trolox is a
vitamin E analogue acting as a direct radical scavenger (Iuliano
et al., 1999). The enzyme inhibitor diphenyleneiodonium chloride
(DPI; Sigma) was dissolved in dimethylsulfoxide (DMSO)
and applied to the cells at a final concentration of 10 μM. No toxic
effects were observed. The enzyme inhibitor VAS2870
(Calbiochem) was dissolved in DMSO and used at a final con-
centration of 10, 20 or 30 μM.
The highest DMSO concentration present in the culture
medium was 0.05%. Control cells were treated with an equivalent
concentration of vehicle.
Glutathione and ROS assays
Intracellular GSH was assayed upon formation of
S-carboxymethyl derivatives of free thiol with iodoacetic acid,
followed by the conversion of free amino groups to 2,4-
dinitrophenyl derivatives by reaction with 1-fluoro-2,4-
dinitrobenzene as previously described (Baldelli et al., 2008).
Data are expressed as nmol GSH/mg protein. Protein concen-
tration was assayed by the Lowry method (Lowry et al., 1951).
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ROS were detected by cytofluorimetric analysis as pre-
viously reported (Aquilano et al., 2006). Briefly, cells were
incubated for 1 h at 37°C with 50 μM dichlorodihydro-
fluorescein diacetate (DCF-DA) in RPMI. Incubation with
0.1 mM tert-butyl hydroperoxide for 30 min was used as
positive control. Then, cells were scraped, washed and
resuspended in PBS. The fluorescence intensity of 10 000 cells
from each sample was measured using a FACScalibur instru-
ment (Becton Dickinson, San Jose, USA). Data were analyzed
using WinMDI 2.8 software.
shRNA expression plasmid transfection
The following shRNA plasmids specific for NOX4 were obtained
from Sigma-Aldrich: NM_016931.2-412S1C1; NM_016931.2-
1015S1C1; NM_016931.2-619S1C1; NM_016931.2-559 S1C1;
and NM_016931.2-1457S1C1. NCI-H292 and HEK-293 cells
were transfected using the jetPEI transfection reagent (Polyplus-
Transfection, Illkirch, France) according to the manufacturer’s
protocol. Briefly, a transfection mixture containing jetPEI, NaCl
and plasmid DNA was incubated at room temperature for 20
minutes and then added drop-wise to the culture medium of cells
at 60% confluence (24 h after plating). NCI-H292 cells were
exposed to the transfection mixture for 24 h, as this time was
sufficient to significantly decrease NOX4 expression, while HEK-
293 cells were exposed for about 72 h. Then, cells were washed
with PBS and infected with PR8 at 0.1 MOI or mock-infected
at 37°C for 1 h. After the viral challenge, cells were washed
with PBS and cultured with fresh medium containing 2% FBS (up
to 24 h).
Western blotting
Cells were detached, washed with cold PBS and centrifuged at
700 g for 10 min. The pellet was lysed in cold lysis buffer
(10 mM Tris pH 7.4, 150 mM NaCl and 0.25% NP-40) contain-
ing protease and phosphatase inhibitors, for 30 min on ice.
Lysates were centrifuged at 10 000 g for 30 min at 4°C to
remove debris. Total protein in the supernatant was quantified
using the Bradford method (Bio-Rad). Lysates were diluted in
SDS sample buffer containing 10% β-mercaptoethanol, sepa-
rated by SDS-PAGE, and blotted onto nitrocellulose mem-
branes. The membranes were blocked with 10% non-fat dry
milk in Tris-buffered saline containing 0.01% Tween-100 for 1 h
at room temperature (RT). Primary antibodies, used at final
concentration of 1 μg ml−1, included mouse monoclonal anti-
gp91-phox IgG1 (anti-NOX2; Santa Cruz Biotechnology), rabbit
polyclonal anti-NOX4 IgG (Santa Cruz Biotechnology), mouse
monoclonal anti-actin (Sigma Aldrich), mouse monoclonal anti-
tubulin (Sigma Aldrich), rabbit polyclonal anti-p38 IgG (Santa
Cruz Biotechnology), rabbit polyclonal anti-phospho-p38 IgG
(Santa Cruz Biotechnology), rabbit polyclonal anti-phospho-
p44/42 MAPK (ERK1-2) IgG (Cell Signaling Technology), rabbit
polyclonal anti-p44/42 MAPK (ERK1-2) IgG (Cell Signaling
Technology), and goat polyclonal anti-influenza A virus IgG
(Chemicon). Bound antibodies were revealed using horseradish
peroxidase-conjugated secondary antibodies (Jackson) followed
by enhanced chemiluminescence (GE Healthcare Life Sci-
ences). Densitometry was done using Quantity One 1-D Analy-
sis software (Bio-Rad).
Immunofluorescence assay
Cells were fixed with 4% paraformaldehyde in PBS for 20 min
at room temperature and washed with PBS. Cells were
permeabilized with 0.1% Triton X-100 in PBS at room tempera-
ture for 5 min. After blocking with 3% non-fat dry milk for 30 min,
cells were incubated with mouse monoclonal anti-influenza A
nucleoprotein (AbD Serotec); bound antibodies were revealed
with goat anti-mouse IgG conjugated with Alexa Fluor 568
(Molecular Probes). After washing, nuclei were stained with
1 μg ml−1 4′,6-diamidino-2-phenylindole (DAPI; Molecular
Probes) in PBS for 15 min at room temperature. Fluorescent
images were acquired on an Olympus IX70 microscope equipped
with Nanomover and softWoRx DeltaVision image acquisition
software (Applied Precision, WA, USA) and a U-PLAN-APO 60×
objective. Images were captured under constant exposure time,
gain and offset. To improve the contrast and resolution of digital
images captured in the microscope, they were elaborated with
deconvolution software.
Statistical analyses
Differences between samples groups were tested for significance
using Student’s t-test or two-way ANOVA. A value of P < 0.05 was
considered to indicate significance.
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Fig. S1. NOX4 supports the replication of different influenza
virus strains in both NCI-H292 and A549 cells. A. Cells were
infected with PR8, NWS or ULSTER virus, and cultured in the
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absence or presence of DPI for 8 h before the conditioned
medium was assayed. Haemagglutination assay (***P < 0.0001;
*P < 0.01).
Fig. S2. NOX4 supports influenza virus replication in HEK-293
cells.
A. HEK-293 cells were transfected with plasmids encoding
shRNAs specific to NOX4 or with a control plasmid encoding a
non-targeting shRNA. The Western blot was sequentially probed
with anti-NOX4 antibody and anti-tubulin antibody. Data are rep-
resentative of two independent experiments.
B and C. Viral load in medium of HEK-293 cells transfected with
non-targeting or NOX4-specific shRNA expression plasmids
before infection with PR8. (B) Haemagglutination assay
(***P < 0.001). (C) Plaque assay (**P < 0.01).
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